Will Listing on the NASDAQ Help Green Organic Dutchman’s (TSX:TGOD) Stock Price Rise?

Green Organic Dutchman Holdings Ltd (TSX:TGOD) could soon be facing a lot more pressure and scrutiny from analysts as the company looks to trade its shares on the NASDAQ.

question marks written reminders tickets

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Green Organic Dutchman Holdings Ltd (TSX:TGOD) has been struggling over the past 12 months. The company that started hot out of the gate with the expectation that it would be a key brand once the edibles market gets going has fallen flat ever since.

After reaching a peak of more than $10 a share back in September of last year, the stock has been nowhere near that mark ever since.

Instead, over the past month, TGOD has struggled to even stay above $3 a share. Its limited sales for its lack market share has made it a stock that cannabis investors have overlooked — and for good reason, as the stock trades at around 200 times its sales with growing losses.

Company looks to NASDAQ listing to draw in more investors

TGOD recently announced that it had submitted an application to list its shares on the NASDAQ. Currently, the stock trades only on the TSX, unlike many larger cannabis companies that trade on a major U.S. exchange as well.

It hopes to trade on the NASDAQ under the same ‘TGOD’ symbol it uses on the TSX.

A key reason for the move is to be able to tap into more investors. In the company’s press release, CEO Brian Athaide stated, “This is an important step in the growth of TGOD, one that will broaden our investor base and increase access for international investors as we build the leading global organic cannabis brand.”

While it’s true that the move will allow TGOD to tap into more investors, it also means that the company will also face more scrutiny from more analysts.

A good example of that pressure is what Constellation Brands faced when its results were weighed down as a result of Canopy Growth‘s disappointing quarter.

Likely feeling the pressure to fix the problem, Constellation ended up removing high-profile Co-CEO Bruce Linton from managing Canopy Growth.

Having access to larger investors can certainly help a company grow and rise in value, but it can also create challenges along the way.

Activist investors may think they know better than a company’s management and try to pressure it into making significant changes, with the added pressure of meeting earnings numbers and estimates on an even larger scale.

Why TGOD still has a long way to go from being an investable company

TGOD can list on all the exchanges it desires, but at the end of the day, it needs numbers for investors to justify buying shares of the company.

While TGOD may believe in its strong growth prospects for the edibles market, that’s no longer enough to win investors over anymore.

There needs to be something tangible that investors can hang their hats on to justify that TGOD is a good buy. And with earnings to be released this coming week, there’s no better opportunity than the present for investors to see how the company has been progressing.

However, with edibles not legal just yet, at minimum, I’d expect we’re probably a year away (at least) from seeing whether TGOD is the real deal or not. Today, the stock is still a very speculative buy.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »